ROCHE GS (Switzerland) Today

ROG -  Switzerland Stock  

CHF 351.90  1.55  0.44%

ROCHE GS is selling for under 351.90 as of the 3rd of August 2021; that is 0.44% increase since the beginning of the trading day. The stock's lowest day price was 348.55. ROCHE GS has less than a 18 % chance of experiencing some financial distress in the next two years of operation and had a solid performance during the last 90 days. Equity ratings for ROCHE GS are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 4th of July 2021 and ending today, the 3rd of August 2021. Click here to learn more.
 Market Performance
21 of 100
  Odds Of Distress
Less than 18
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

ROCHE GS Stock Profile

Roche Holding AG engages in the prescription pharmaceuticals and diagnostics businesses in Switzerland, Germany, and internationally. The company was founded in 1896 and is headquartered in Basel, Switzerland. ROCHE GS operates under Drug ManufacturersGeneral classification in Switzerland and is traded on Switzerland Exchange. It employs 101465 people. more on ROCHE GS
Legal NameROCHE GS
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of ROCHE GS's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
ROCHE GS (ROG) is traded on Switzerland Exchange in Switzerland and employs 101,465 people. The company currently falls under 'Mega-Cap' category with current market capitalization of 308.78 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ROCHE GS's market, we take the total number of its shares issued and multiply it by ROCHE GS's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. ROCHE GS operates under Healthcare sector and is part of Drug Manufacturers—General industry. The entity has 693.13 M outstanding shares. ROCHE GS has accumulated about 12.34 B in cash with 18.57 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 14.47.
Check ROCHE GS Probability Of Bankruptcy
ROCHE GS secures a total of six hundred ninety-three million one hundred thirty thousand outstanding shares. 30% of ROCHE GS outstanding shares are owned by institutions. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Therefore, institutional investors are subject to different rules and regulation than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or about to change. Please note that no matter how much assets the company retains, if the real value of the company is less than the current market value, you may not be able to make money on it.

Ownership Allocation (%)

Check ROCHE Ownership Details

ROCHE Stock Price Odds Analysis

What are ROCHE GS's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of ROCHE GS jumping above the current price in 90 days from now is about 15.28%. The ROCHE GS probability density function shows the probability of ROCHE GS stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon ROCHE GS has a beta of -0.0388 indicating as returns on benchmark increase, returns on holding ROCHE GS are expected to decrease at a much lower rate. During the bear market, however, ROCHE GS is likely to outperform the market. Additionally, the company has an alpha of 0.1742, implying that it can generate a 0.17 percent excess return over DOW after adjusting for the inherited market risk (beta).
 Odds Down 351.9HorizonTargetOdds Up 351.9 
84.60%90 days
Based on a normal probability distribution, the odds of ROCHE GS to move above the current price in 90 days from now is about 15.28 (This ROCHE GS probability density function shows the probability of ROCHE Stock to fall within a particular range of prices over 90 days) .

ROCHE GS Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. ROCHE GS market risk premium is the additional return an investor will receive from holding ROCHE GS long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in ROCHE GS. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although ROCHE GS's alpha and beta are two of the key measurements used to evaluate ROCHE GS's performance over the market, the standard measures of volatility play an important role as well.

ROCHE Stock Against Markets

Picking the right benchmark for ROCHE GS stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in ROCHE GS stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for ROCHE GS is critical whether you are bullish or bearish towards ROCHE GS at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in ROCHE GS without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Money Managers Now


Money Managers

Screen money managers from public funds and ETFs managed around the world
All  Next Launch Module
Additionally, take a look at Your Equity Center. Note that the ROCHE GS information on this page should be used as a complementary analysis to other ROCHE GS's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Tools for ROCHE Stock

When running ROCHE GS price analysis, check to measure ROCHE GS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ROCHE GS is operating at the current time. Most of ROCHE GS's value examination focuses on studying past and present price action to predict the probability of ROCHE GS's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ROCHE GS's price. Additionally, you may evaluate how the addition of ROCHE GS to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Fund Screener
Find activelly-traded funds from around the world traded on over 30 global exchanges
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital